US2005004356A1PendingUtilityA1

Linker nucleoside, its preparation and use

Assignee: NANOGEN RECOGNOMICS GMBHPriority: Sep 22, 1997Filed: Mar 2, 2004Published: Jan 6, 2005
Est. expirySep 22, 2017(expired)· nominal 20-yr term from priority
Y02P20/55A61K 47/549G01N 33/532C07H 19/04C07H 1/00A61K 47/54C07H 21/00B82Y 10/00H10K 85/761
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a linker nucleoside, its preparation and use for the covalent bonding of biomolecules to oligonucleotides, in particular p-RNA oligonucleotides.

Claims

exact text as granted — not AI-modified
1 . A process for the preparation of a pentopyranosyl nucleotide containing nucleic acid comprising 
 a) bonding a 3′-, 4′-protected nucleoside of the formula                          to a solid phase,    wherein R 1  is selected from the group consisting of H, OH, phosphoramidite, Br, Cl, and an oligomer;    wherein S c1  is selected from the group consisting of H, acyl group, trityl group, allyloxycarbonyl group, phosphoester(III), phosphoester(V), thiophosphate(V), phosphonate, and phosphoramidite;    wherein S c2  is selected from the group consisting of H, acyl group, trityl group, allyloxycarbonyl group, phosphoester(III), phosphoester(V), thiophosphate(V), phosphonate, phosphoramidite, and an oligomer;    wherein B is a nucleobase selected from the group consisting of purine, 2,6-diaminopurine, 6-purinethiol, pyridine, pyrimidine, adenine, guanine, isoguanine, 6-thioguanine, xanthine, hypoxanthine, thymine, cytosine, isocytosine, indole, tryptamine, N-phthaloyltryptamine, uracil, caffeine, theobromine, theophylline, benzotriazole, and acridine; and    wherein X is an H or a linker of the formula —(CH 2 ) n —Y, wherein Y is a protected or deprotected nucleophile or electrophile;    b) reacting the 3′-, 4′-protected nucleoside bonded to a solid phase according to step (a) with a phosphitylated 3′-, 4′-protected nucleoside of the same formula in step (a), after deprotecting the 4′ position of the nucleoside bonded to the solid phase;    c) oxidizing the coupled product from step (b); and    d) repeating steps (b) and (c) using nucleosides or linker nucleosides until the desired nucleic acid is produced, wherein the nucleic acid contains at least one linker of the formula —(CH 2 ) n —Y.

Join the waitlist — get patent alerts

Track US2005004356A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.